![](//www.4rfv.com/images/no_image.jpg)
Amsterdam, the Netherlands and San Diego, CA - Royal Philips (NYSE: PHG, AEX: PHIA) and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care. The new handheld test will be based on Philips' Minicare I-20 system. The financial details of the agreement were not disclosed.
The collaboration unites Philips' strength in patient monitoring and handheld diagnostics technologies, as well as, clinical decision support applications for use in acute care settings, and Banyan Biomarkers' knowledge of biomolecules that are indicative of neurological injuries.
Point-of-care diagnostics for acute care settings, such as handheld blood tests for Emergency Departments, will play a critical role in improving patient outcomes and reducing healthcare costs, said Marcel van Kasteel, CEO of Handheld Diagnostics at Philips. The joint development agreement with Banyan Biomarkers is another great example of our expansion into this fast growing market. Our innovative Minicare technology platform and partnerships are a firm foundation for our ambition to become a leader in this new growth market for Philips.
A rapid and objective point-of-care test to evaluate traumatic brain injury will help millions of patients throughout the world, said Jackson Streeter MD, CEO, Banyan Biomarkers. This partnership with Philips to develop and commercialize a TBI blood test on the Minicare system is an important step forward in providing physicians and other healthcare providers information to evaluate patients who have suffered a concussion.
Diagnosing concussions is often difficult because the brain injury may not be obvious without a reliable and objective test. Often a CT scan of the patient's brain is found to be normal despite the patient having significant head injury and symptoms. Failure to make a correct diagnosis and timely selection of the appropriate treatment can have serious implications for the patient. According to the United States Centers for Disease Control, there were approximately 2.5 million Emergency Department visits, hospitalizations, or deaths associated with TBI in the US in 2010 [1]. As a result, direct and indirect costs of TBI in the US were approximately USD 76.5 billion [2].
Currently, there is no blood test for use by physicians in the hospital to detect the presence and severity of brain trauma, such as concussion. Following a brain injury, a destructive cascade of biological events continue over hours and days that may worsen the patient's condition. Banyan Biomarkers has identified two proteins that rapidly appear in the blood of patients soon after injury.
The new blood test to detect the proteins will be based on Philips' Minicare I-20 system. The system consists of a handheld analyzer, dedicated software and a single use, disposable cartridge containing the application specific test. Based on Philips' proprietary Magnotech biosensor technology, the Minicare I-20 system is being developed to detect multiple target molecules at low concentrations with a blood sample and to show the results on the analyzer display within minutes.
Mr. van Kasteel added: This partnership will broaden the menu offering on our Minicare I-20 system and will strengthen our competitive position in point-of-care diagnostics for the Emergency Department.
The Minicare activities are part of Philips' Handheld Diagnostics business, which has its headquarters and manufacturing lines at the High Tech Campus in Eindhoven, the Netherlands.
[1] http://www.cdc.gov/traumaticbraininjury/get_the_facts.html
[2] http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6227a2.htm
More from Philips
14/12/2017
Immersive audio-visual experience calms patients and guides them through MR scan...
09/12/2017
3D printing interfacing with Philips IntelliSpace Portal 10 brings innovation into radiology and patient care
December 6, 2017
Amsterdam, the Netherlands a...
25/11/2017
Three quarters of Brits (75%) have fallen asleep without meaning to and 16 per cent even admit to secret napping'
With over 3.4 million undiagnosedi obstr...
25/11/2017
Two year study* found that clinicians' use of Azurion enabled significant re...
24/10/2017
September 12, 2017
London, UK - At Defence and Security Equipment Internatio...
18/09/2017
Philips makes extended commitment to improve the lives of 300 million people in ...
05/09/2017
Reclassification of Philips' shares reflects company's focus on health technology
September 4, 2017
Amsterdam, the Netherlands -'Royal Phili...
14/08/2017
Global report shows patients and healthcare professionals (HCPs) are positive about the benefits offered by connected care technologies - and that they are alre...
08/07/2017
July 06, 2017
Regional oncology center brings together the latest imaging, treatment and clinical informatics technologies from Philips, Singapore Institute...
06/07/2017
July 4, 2017
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHI...
04/07/2017
The only fully automated and completely configurable early warning scoring solut...
15/06/2017
Philips reports sales of EUR 5.7 billion in Q1, with the HealthTech portfolio growing at 3% on a comparable basis; net income improved to EUR 259 million, drive...
15/06/2017
Study showed use of home non-invasive ventilation in conjunction with home oxyge...
15/06/2017
Debuts IntelliSpace Oncology, an integrated oncology informatics solution enabli...
15/06/2017
Contract sees the first installation of Philips DoseWise 9.0 radiation managemen...
08/04/2016
Philips' design excellence recognized with 37 prestigious Red Dot awards in 2016
Philips' design excellence recognized with 37 prestigious Red Dot awa...
06/04/2016
Philips introduces Aging Well Services, bringing personalized connected health o...
07/03/2016
Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today announce...
03/03/2016
First HealthSuite Labs innovation center in North America spurs co-creation of c...
03/03/2016
Amsterdam, The Netherlands - Royal Philips (NYSE:PHG, AEX: PHIA) today announced that it is the world's largest patent applicant for patents filed at the Eu...
25/02/2016
Enterprise clinical informatics and advanced patient monitoring captures data an...
25/02/2016
Stockholm, Sweden - Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it...
23/02/2016
New Vendor Neutral Archiving solution delivers medical images from all disciplines to clinicians across multiple departments and locations within the health sy...
23/02/2016
Powered by Philips' HealthSuite digital platform and Amazon Web Services, ne...
23/02/2016
Solution to seamlessly connect wearable biosensor, clinical decision support sof...
23/02/2016
Multi-year agreements for telemonitoring of ICU patients will allow health syste...
04/02/2016
London, UK and Amsterdam, the Netherlands - BTG plc (LSE: BTG), a global special...
01/02/2016
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jean Botti as Chief Innovation and Strategy Officer as part...
26/01/2016
Fourth-quarter highlights
Comparable sales up 2%, driven by 4% growth in the HealthTech portfolio
Currency-comparable order intake up 15%, driven by North Ame...
07/01/2016
Amsterdam, the Netherlands and San Diego, CA - Royal Philips (NYSE: PHG, AEX: PH...
06/01/2016
Andover, MA - Royal Philips (NYSE: PHG, AEX: PHIA) today announced it will showc...
30/11/2015
Fully integrated radiology solutions help provide early detection and clinical i...
18/11/2015
Amsterdam, the Netherlands - Marking World COPD Day, Royal Philips (NYSE:PHG, AE...
18/11/2015
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG; AEX: PHIA) today announce...
13/11/2015
Best, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has enhanced its strength in image-guided therapy innovation with the estab...
10/11/2015
Collaboration is based on managed equipment services model to advance medical te...
29/10/2015
Philips BlueControl is the world's first wearable UV-free blue LED light med...
26/10/2015
Third-quarter highlights
Comparable sales up 2%, driven by North America, Asia Pacific and Central & Eastern Europe
Currency-comparable order intake up 2%, dr...
20/10/2015
London, UK - OCTOBER 20, 2015 - Today, Royal Philips (NYSE: PHG, AEX: PHIA), the...
15/10/2015
London, UK - Philips Respironics, a business of Royal Philips (NYSE: PHG AEX: PH...
13/10/2015
System is first of its kind in the U.S.
Philips is Elekta's MRI technology ...
13/10/2015
Reading, UK - Royal Philips (NYSE: PHG; AEX: PHIA), LATCH Welsh Children's C...
09/10/2015
AWS IoT enriches Philips HealthSuite digital platform with greater Internet of T...
02/10/2015
Guildford, UK - Royal Philips (NYSE: PHG AEX: PHIA) today announced the release ...